We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
Taking action by sending messages to your Congressional delegation makes a difference, and our online campaigns make it easy to do. Don't take it from us, hear from Rosa DeLauro, Ranking Member of the House Appropriations Committee, why your voice matters.
Funding for the National Institutes of Health (NIH) and other health agencies is in jeopardy as the U.S. Congress has not completed FY 2025 funding bills. Funding runs out December 20. In addition, there are significant differences between the proposals in the House of Representatives and the Senate with members of the House advocating for cuts, policy changes, and a massive reorganization of the NIH. It is critical that your members of Congress hear from you about the importance of funding biomedical research.
Funding for SDP is set to expire on December 31, 2024 unless Congress passes legislation to extend the program. Join the Endocrine Society in urging Congress to continue this program by passing legislation that would extend it for two years at $170 million per program per year. It is critical that members of Congress hear from you, the constituent, about the importance of this important program.
The Endocrine Society is urging the Senate to pass the bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. In 2022, President Biden signed the Inflation Reduction Act into law, which capped insulin costs for Medicare beneficiaries. However, insulin remains unaffordable for people with private insurance. Join our campaign today to remind your Senators that addressing insulin affordability for people with private insurance is a top priority.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.